# Nurix Therapeutics, Inc. (NRIX) - Q4 2025 earnings

Reported January 28, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | $13.6M | $13.4M |
| EPS | $-0.82 | $-0.84 |

Earnings filing reader: [8-K 0001549595-26-000013](https://www.opencapital.sh/filings/0001549595-26-000013)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001549595-26-000013.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1549595/000154959526000013/0001549595-26-000013-index.htm)
Periodic report: 10-K - https://www.sec.gov/Archives/edgar/data/1549595/000154959526000016/0001549595-26-000016-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/nrix/earnings/q4-2025